Emergent biosolution stock.

Nov 27, 2023 · Complete Emergent Biosolutions Inc. stock information by Barron's. View real-time EBS stock price and news, along with industry-best analysis. EBS earnings call for the period ending September 30, 2023. Image source: The Motley Fool. Emergent BioSolutions ( EBS 11.68%) Q3 2023 Earnings Call. Nov 08, 2023, 5:00 p.m. ET. Emergent BioSolutions Inc EBS Morningstar Rating Unlock Stock XNYS Rating as of Nov 29, 2023 Summary Chart News Price vs Fair Value Sustainability …Emergent BioSolutions. GAITHERSBURG, Md., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS) today announced a sharpened strategic focus on protecting and enhancing life through ...

People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.

The latest price target for Emergent BioSolutions ( NYSE: EBS) was reported by Benchmark on Tuesday, August 29, 2023. The analyst firm set a price target for 0.00 expecting EBS to fall to within ...Emergent BioSolutions Receives NYSE Notice Regarding Delayed Form 10-Q Filing. GAITHERSBURG, Md., Nov. 24, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today confirmed that on November 16, 2023, the New York Stock Exchange (NYSE) sent a notice that the company is not in compliance with Section 802.01E of the NYSE Listed Company Manual due to a delay in filing its Quarterly ...

Emergent became a publicly traded company in 2006, with its stock trading on the New York Stock Exchange under the symbol EBS. Mergers, acquisitions and joint ...17 thg 8, 2022 ... Emergent Biosolutions Inc's trailing 12-month revenue is $1.7 billion with a 17.5% profit margin. Year-over-year quarterly sales growth most ...Oct 9, 2023 · NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown. The Split Adjustment Factor is a cumulative factor which encapsulates all splits since the date shown. Emergent BioSolutions. GAITHERSBURG, Md., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced the appointment of Neal Fowler and Don DeGolyer to its Board of ...Get the latest Emergent Biosolutions Inc (EBS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

May 15, 2023 · Emergent BioSolutions has been quite the up-and-down stock of late. On Monday, it had an up session on the market, creeping northward by 1.2% and exceeding the S&P 500 's gain of 0.3%.

Emergent Biosolutions belongs to the Zacks Medical - Biomedical and Genetics industry. Another stock from the same industry, Ultragenyx RARE , closed the last trading session 3.7% higher at $39.07.

During today's call, Emergent may make projections and other forward-looking statements related to their business, future events, the prospects, or future performance. Find the latest Emergent BioSolutions Inc. (EBS) stock quote, history, news and other vital information to help you with your stock trading and investing.Emergent BioSolutions Reports FDA Advisory Committees’ Unanimous Vote in Favor of NARCAN® (naloxone HCI) Nasal Spray for Over-the-Counter Use. February 15, 2023 17:19 ET ...Emergent Biosolutions, Inc. Common Stock (EBS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. May 15, 2023 · Emergent BioSolutions has been quite the up-and-down stock of late. On Monday, it had an up session on the market, creeping northward by 1.2% and exceeding the S&P 500 's gain of 0.3%. NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown. The Split Adjustment Factor is a cumulative factor which encapsulates all splits since the date shown.The stock price of government contractor Emergent BioSolutions has fallen sharply since the disclosure at the end of March that production problems at the firm’s plant in Baltimore had ruined 15 ...

Mar 30, 2023 · Emergent Biosolutions Inc Stock Price History. Emergent Biosolutions Inc’s price is currently down 17.77% so far this month. During the month of March, Emergent Biosolutions Inc’s stock price has reached a high of $12.54 and a low of $7.74. Over the last year, Emergent Biosolutions Inc has hit prices as high as $44.04 and as low as $7.74. 146.71. +1.95%. 40.54M. View today's Emergent Biosolutions Inc stock price and latest EBS news and analysis. Create real-time notifications to follow any changes in the live stock price.Dec 1, 2023 · Emergent BioSolutions Awarded 10-Year BARDA Contract Valued at up to a Maximum of $704 Million for Advanced Development and Procurement of Ebanga™ Treatment for Ebola. GAITHERSBURG, Md., July 31, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it was awarded a 10-year contract by the Biomedical Advanced ... Emergent Biosolutions Inc Stock Price History. Emergent Biosolutions Inc’s price is currently up 27.51% so far this month. During the month of April, Emergent Biosolutions Inc’s stock price has reached a high of $13.67 and a low of $9.47. Over the last year, Emergent Biosolutions Inc has hit prices as high as $43.33 and as low as $7.74.Access to Narcan, a lifesaving drug that reverses overdoses, has been limited by Emergent BioSolutions’ hunt for profits, including a five-year delay in bringing it over the counter.

Mar 27, 2023 · Emergent Biosolutions Inc Stock Price History. Emergent Biosolutions Inc’s price is currently down 28.43% so far this month. During the month of March, Emergent Biosolutions Inc’s stock price has reached a high of $12.54 and a low of $7.74. Over the last year, Emergent Biosolutions Inc has hit prices as high as $45.14 and as low as $7.74. Oct 9, 2023 · NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown. The Split Adjustment Factor is a cumulative factor which encapsulates all splits since the date shown.

Emergent BioSolutions reported $354.3M in Stock for its fiscal quarter ending in June of 2023. Data for Emergent BioSolutions | EBS - Stock including ...MORE: In wake of Emergent BioSolutions' vaccine problems, CEO's stock trades come into focus The recent cross-contamination at the Baltimore plant is not the first time Emergent has had to answer ...Shares of Emergent BioSolutions (NYSE: EBS) were tumbling 10.6% lower as of 11:29 a.m. ET on Tuesday. The decline came after S&P Global's S&P Dow Jones Indices announced that Advance Auto Parts will replace Emergent BioSolutions in the S&P SmallCap 600 index. S&P Dow Jones Indices said that … See more1 thg 4, 2021 ... ... stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide. The News with ...Our Mission. At Emergent, we develop, manufacture, and deliver protections against public health threats through a pipeline of innovative vaccines and therapeutics worldwide. For 25 years, we’ve been at work defending people from things we hope will never happen—so that we’re prepared, just in case they ever do.Verdict: Emergent BioSolutions lost $2.23 a share in FY2022 on revenues of $1.12 billion. The current analyst firm consensus has that loss dropping just below a buck a share in FY2023 even as ...EBS - Emergent Biosolutions Inc - Stock screener for investors and traders, financial visualizations.1 thg 4, 2021 ... ... stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide. The News with ...Emergent BioSolutions Receives NYSE Notice Regarding Delayed Form 10-Q Filing. GAITHERSBURG, Md., Nov. 24, 2023 (GLOBE NEWSWIRE) -- Emergent …A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 ...

Sep 5, 2023 · Emergent BioSolutions Inc. shareholders can proceed in part with a lawsuit over sharp stock declines following news of contaminated Covid-19 vaccine batches at the company’s production facility and a canceled government contract, a federal court ruled. The investors plausibly alleged numerous intentional, material misrepresentations and ...

May 15, 2023 · Emergent BioSolutions has been quite the up-and-down stock of late. On Monday, it had an up session on the market, creeping northward by 1.2% and exceeding the S&P 500 's gain of 0.3%.

Stock Quote & Chart. Data Provided by Refinitiv. Minimum 15 minutes delayed. The Investor Relations website contains information about Emergent BioSolutions Inc.'s business for stockholders, potential investors, and financial analysts.Emergent Biosolutions shares plunged by more than 37% on Friday after the company disclosed it "mutually agreed" with the federal government to cancel a $628 million contract after botching Covid ...Emergent BioSolutions stock has received a consensus rating of buy. The average rating score is and is based on 5 buy ratings, 3 hold ratings, and 1 sell ratings.Sep 5, 2023 · Emergent BioSolutions Inc. shareholders can proceed in part with a lawsuit over sharp stock declines following news of contaminated Covid-19 vaccine batches at the company’s production facility and a canceled government contract, a federal court ruled. The investors plausibly alleged numerous intentional, material misrepresentations and ... Emergent Biosolutions (EBS) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of $0.32. This compares to earnings of $4.50 per share a year ago.Find the latest Emergent BioSolutions Inc. (EBS) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.That was the recommendation in January by executives at the biotech firm Emergent BioSolutions. The board of directors agreed, signing off on nearly $8 million in cash and stock awards for five ...Shares of Emergent BioSolutions (NYSE: EBS) were tumbling 10.6% lower as of 11:29 a.m. ET on Tuesday. The decline came after S&P Global's S&P Dow Jones Indices announced that Advance Auto Parts will replace Emergent BioSolutions in the S&P SmallCap 600 index. S&P Dow Jones Indices said that … See moreEmergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. [2] It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes. Emergent BioSolutions Reports Financial Results for Fourth Quarter 2022. Reports Q4 2022 total revenues of $331M resulting in FY 2022 total revenues of $1,121M, in line with prior guidance. Reports Q4 2022 net loss of $88M and FY 2022 net loss of $224M. Reports Q4 2022 adjusted EBITDA of $34M and FY 2022 adjusted EBITDA of $26M, in line with ...

Emergent Biosolutions Inc Stock Price History. Emergent Biosolutions Inc’s price is currently down 11.31% so far this month. During the month of March, Emergent Biosolutions Inc’s stock price has reached a high of $12.54 and a low of $10.89. Over the last year, Emergent Biosolutions Inc has hit prices as high as $45.14 and as low as …Emergent Biosolutions is part of the Zacks Medical - Biomedical and Genetics industry. Over the past month, Axsome Therapeutics (AXSM), a stock from the same industry, has gained 16.4%.Has the stock finally bottomed out? Shares of drug manufacturer Emergent BioSolutions ( EBS -2.63%) are down 75% in the past 12 months. Investors have been turning to safer investments amid the ...Robert G. Kramer Sr. to Retire. Haywood Miller to Serve as Interim CEO. GAITHERSBURG, Md., June 27, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS, “Emergent” or the “Company”) today announced that Robert G. Kramer Sr. has informed the Board of Directors of his intention to retire from Emergent. Mr.Instagram:https://instagram. vision insurance plans pennsylvaniawhere to buy verano stockreit mortgageforeign exchange trading software Emergent Biosolutions stock has rallied 111% since late March (vs. about 53% for the S&P 500) to its current level around $105. The stock fell to a low of $50 in late March when a rapid increase ... what did the feds do todayspdr sector etfs Emergent Biosolutions (EBS) delivered earnings and revenue surprises of -8.16% and 59.20%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock? lighting port Feb 16, 2023 · Emergent Biosolutions EBS shares ended the last trading session 12.5% higher at $14.92. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. Discover historical prices for EBS stock on Yahoo Finance. View daily, weekly or monthly format back to when Emergent BioSolutions Inc. stock was issued.